Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Samsung/Merck & Co’s Herceptin biosimilar

pharmaphorumJanuary 23, 2019

Tag: FDA , Samsung , Merck , Herceptin biosimilar

PharmaSources Customer Service